Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.77 USD | -8.71% | +1.92% | -47.51% |
May. 09 | Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M | MT |
May. 09 | Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 26.8M | Sales 2025 * | 37M | Capitalization | 6.34M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.24 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.17 x |
P/E ratio 2024 * |
-0.25
x | P/E ratio 2025 * |
-0.35
x | Employees | 133 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.32% |
Latest transcript on Telesis Bio, Inc.
1 day | -8.71% | ||
1 week | +1.92% | ||
Current month | -7.60% | ||
1 month | -36.53% | ||
3 months | -59.57% | ||
6 months | -47.65% | ||
Current year | -47.51% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Gibson
FOU | Founder | 47 | 11-03-23 |
Eric Esser
CEO | Chief Executive Officer | 54 | 22-04-30 |
William Kullback
DFI | Director of Finance/CFO | 64 | 23-08-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jami Nachtsheim
BRD | Director/Board Member | 65 | 21-05-31 |
Director/Board Member | 65 | 21-04-30 | |
Gregory Herrema
BRD | Director/Board Member | 58 | 23-10-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 3.77 | -8.71% | 19,397 |
24-06-04 | 4.13 | +2.73% | 6,690 |
24-06-03 | 4.02 | -1.47% | 39,289 |
24-05-31 | 4.08 | +11.32% | 68,085 |
24-05-30 | 3.665 | -0.92% | 12,745 |
Delayed Quote Nasdaq, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.51% | 6.34M | |
+8.38% | 220B | |
+15.78% | 198B | |
+23.68% | 148B | |
+31.27% | 112B | |
+4.07% | 66.17B | |
+14.19% | 52.47B | |
+4.70% | 50.77B | |
-3.93% | 38.97B | |
-0.47% | 35.13B |
- Stock Market
- Equities
- TBIO Stock